Vivoryon Therapeutics NV

04/24/2024 | Press release | Distributed by Public on 04/24/2024 02:04

Vivoryon Therapeutics N.V., - Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates

Vivoryon Therapeutics N.V.

Vivoryon Therapeutics N.V.

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

Registration date24 apr 2024 - 07:12
Statutory nameVivoryon Therapeutics N.V.
TitleVivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates

Date last update: 24 April 2024